IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER

Autoimmune Hemolytic Anemia

City of Hope Medical Centermonoclonal_antibodyPhase 2Active

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 95/ 100

Competitive context

9 Active assets in the Autoimmune Hemolytic Anemia cohort.

Asset / Sponsor	Phase	Rating
Ibrutinib Gruppo Italiano Malattie EMatologiche dell'Adulto	Phase 2	CCC
Inno-206 City of Hope Medical Center	Phase 2	CCC
Acalabrutinib City of Hope Medical Center	Phase 2	CCC
(+)-VINCRISTINE City of Hope Medical Center	Phase 2	CCC
Bcma Car T Cells Zhejiang University	Early Phase 1	C

View all 9 →

Same molecule, other indications

IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER is also rated in:

Recurrent Adult Burkitt LymphomaDormant

BBB

Indicative ·

78 / 100

View asset →

Recurrent Adult Diffuse Small Cleaved Cell LymphomaDormant

BBB

Indicative ·

76 / 100

View asset →

lymphoblastic lymphomaDormant

BBB